Long-term tolerability of etoricoxib in patients with previous reactions to non-steroidal anti-inflammatory drugs.

Di Leo, E; Aloia, A M; Nettis, E; Cardinale, F; Foti, C; Distaso, M; Ferrannini, A; Vacca, A

Di Leo, E; Aloia, A M; Nettis, E; Cardinale, F; Foti, C; Distaso, M; Ferrannini, A; Vacca, A.

Int J Immunopathol Pharmacol ; 22(4): 1131-4, 2009.

Article in En | MEDLINE | ID: mdl-20074479

Subject(s)

Anti-Inflammatory Agents, Non-Steroidal/adverse effects; Cyclooxygenase 2 Inhibitors/therapeutic use; Drug Hypersensitivity/etiology; Pyridines/therapeutic use; Sulfones/therapeutic use; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Cyclooxygenase 2 Inhibitors/administration & dosage; Cyclooxygenase 2 Inhibitors/adverse effects; Etoricoxib; Female; Humans; Male; Middle Aged; Pyridines/administration & dosage; Pyridines/adverse effects; Retrospective Studies; Single-Blind Method; Sulfones/administration & dosage; Sulfones/adverse effects; Young Adult

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Sulfones / Anti-Inflammatory Agents, Non-Steroidal / Drug Hypersensitivity / Cyclooxygenase 2 Inhibitors Type of study: Observational_studies Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Int J Immunopathol Pharmacol Journal subject: ALERGIA E IMUNOLOGIA / FARMACOLOGIA / PATOLOGIA Year: 2009 Document type: Article Country of publication: United kingdom

Search on Google

Add to My VHL

XML

PubMed Links